Epilepsy Flashcards
Epilepsy
Chronic neurological disorder manifesting by repeated epileptic seizures, which result from paroxysmal uncontrolled discharge of neurone within CNS
Clinical manifestations range from major motor convulsion to brief period of lack of awareness
Pathogenesis
Animal models of focal epilepsy suggest central role for excitatory NT glutamate (inc in epilepsy) and inhibitory gamma am ion acid butyric acid (dec)
Epidemiology and course
Any age
5% of population
0.5-1% have recurrent
70% well controlled with drugs
30% partially resistant to drug treatment= intractable epilepsy
Classification
Based upon nature of seizure rather than presence of absence of an underlying cause
Focal seizures- account for 80% of adult epilepsies
Simple partial seizures
Complex partial seizures
Generalised seizures
Partial seizure types
Focal
Jacksonia (focal motor seizures)
Temporal lobe
Focal seizures
Specific area of brain has generated abnormal electrical activity
Clinical features depend on area
Characterised by aura
Jacksonia
Simple motor seizure which originates in motor cortex
Jerking movements (angle of mouth –> limbs)
Weakness may persist for several hours- Todds’ paralysis
Temporal lobe seizures
Partial seizures characterised by feeling of reality (jamais vu) or familiarity (deja vu)
Absence attacks
Vertigo
Hallucinations
Generalised seizures
Tonic/clonic (grad mal seizures, generalised major convulsion)
DDX
Syncope attacks
Cardiac arrhythmias
Migraine
Hypoglycaemia
Panic attack
Investigation
Concern of clinician is that epilepsy may be symptomatic of a treatable cerebral lesion
Routine- haematology, biochemistry (electrolytes, urea, calcium), x-ray
Specialised neurophysiological investigations- sleep deprived EEG, video EEG monitoring
Advanced investigations- neuropsychology, semi-invasive EEG recording, MR spectroscopy, PET scan
Treatment
Anticonvulsant drugs
Surgery may be necessary
Treatment target is seizure freedom and improvement of QOL
Most common drugs- sodium valproate, lamotrigine (1st line), toprimate (2nd), start slow and simple, mono therapy and careful monitoring over time